Combining pharmacometric models with predictive and prognostic biomarkers for precision therapy in Crohn's disease: A case study of brazikumab by Nan Zhang, Ming Liang Chan, Jing Li, Philip Z. Brohawn, Bo Sun, Inna Vainshtein, Lorin K. Roskos, Raffaella Faggioni, Rada M. Savic

Get full text